Financial News Discussion of TEVA - Teva Pharmaceutical Industries Limited on Squawk On The Street

Financial News for Teva Pharmaceutical Industries Limited (TEVA)

TEVA 3/17/2010 4:00PM 52 Week Price Range Market Capitalization Dividend Yield Recent Dividend
$59.94 $42.77 — $62.17 $55.0 Billion 1.10% $0.48

Want to Sharpen Your Investing?

Learn how Ockham can help investors make informed decisions and slice through the noise. Learn more about Ockham's services.

Sign Up Now for Ockham's Stock Analysis and News Services

Explore Why Ockham?

Quality Analysis
Ockham has fundamental valuations on over 5000 companies which we distribute, to our clients via highly-focused equity reports, weekly newsletters, and analysts' daily market commentary blogs. (Learn More)
Crowd Sentiment
Through our partnership with The Motley Fool, Ockham provides the most robust data on investors' sentiment of individual stocks. This indicator, along with our valuations and our news tracking, helps our clients make informed investment decisions. (Learn More)
Financial News Slicing
With the influx of noise in our lives, it can be exceedingly difficult to separate the essential news from everything else. Ockham's RazorWire tool "slices" through business television and impactful blogs to provide you with the clearest information possible. (Learn More)
Teva Pharmaceutical Industries Limited was discussed on Squawk On The Street which was originally produced by CNBC on 1/19/2010
There was a discussion about Teva Pharmaceutical Industries Limited on Squawk On The Street and RazorWire has captured an important portion of the story below.

The latest news on Squawk On The Street in regards to TEVA came through on RazorWire recently.

Crowd sentiment is favorable on this stock, as measured by the Motley Fool CAPS survey. When taking into account the amount of news coverage each stock normally sees as a percentage of the total, Teva Pharmaceutical Industries Limited has actually sunk a bit in comparison to the others. The Ockham valuation currently has a Fairly Valued stance on TEVA because it trades within the price range that we would expect given current market conditions and fundamentals.

“Why has TEVA decided to go so much higher? As you said, $7 million worth of product alone. > > mike, you know, TEVA is the largest pharmaceutical company in the united states ...” Squawk On The Street Jan 19, 2010 10:10 AM
Since it's appearance on Squawk On The Street: